OncoHost Receives New York State Laboratory Permit for Precision Oncology Test
The permit enables the company to offer its PROphetNSCLC test to physicians and patients across New York State, completing nationwide availability.
Category: Cancer
Cancer
Latest
Cancer
Latest
AI-Powered Blood Test Shows Promise for Early Lung Cancer Detection
A new blood-based test that combines four protein markers with artificial intelligence has demonstrated potential for early lung cancer detection in a multicenter retrospective study.
Cancer
Latest
Clinical Study to Evaluate ctDNA Test for Guiding Lung Cancer Treatment
Haystack Oncology and Rutgers Cancer Institute collaborate on phase II trial examining minimal residual disease testing in stage II/III NSCLC patients.
FDA Grants De Novo Authorization for AI-Powered Prostate Cancer Prognostic Software
The risk stratification tool is designed to predict long-term outcomes for patients with non-metastatic prostate cancer.
Read More
VieCure Adds Summit Cancer Centers to Community Oncology Network
Multi-disciplinary cancer center will implement Halo Intelligence platform to enhance precision oncology capabilities across Pacific Northwest.
Read More
Ultrasensitive MRD Test Shows Greater Prognostic Accuracy Than PET/CT in Lymphoma
Pooled analysis of 137 patients shows the assay achieved 86% sensitivity and 91% specificity for relapse detection in large B-cell lymphoma, leading to NCCN guideline inclusion.
Read More
Blood Test Achieves 85% Accuracy in Predicting Breast Cancer Immunotherapy Response
Researchers develop PIPscore using plasma proteomics to identify triple-negative breast cancer patients most likely to benefit from immunotherapy treatment.
Read More
Mass General Brigham Launches Trials of Blood Test to Guide Post-Surgery Cancer Care
Two studies will evaluate circulating tumor DNA as a guide for post-surgical cancer treatment decisions.
Read More
Colorectal Cancer Screening Surges 62% Among Adults 45-49, Driving Early-Stage Diagnoses
Two new American Cancer Society studies reveal significant increases in colorectal cancer...
Read More
Three Boston Institutions Launch Precision Genomics Initiative for Pediatric Cancer Testing
Dana-Farber Cancer Institute, Boston Children’s Hospital, and Broad Clinical Labs form BrightSeq collaborative to develop novel clinical diagnostic assays for rare pediatric cancers.
Read More
At-Home Cervical Cancer Screening Now Available, Starting in California
This marks the first time a US Food and Drug Adminstration-authorized self-collection device is available for at-home cervical cancer screening in the US.
Read More
Test Gains Medicare Coverage for Early-Stage Breast Cancer Recurrence Monitoring
Coverage marks a step in expanding access to ultra-sensitive molecular residual disease detection for breast cancer patients.
Read More
CyPath Lung Flags Early-Stage Cancer Overlooked by Previous Tests
A case study shows how the noninvasive test detected Stage 1A mucinous adenocarcinoma in a high-risk patient whose previous tests and follow-up scans had suggested a low probability of cancer.
Read More
Declining Cancer Screening Rates Prompt Interest in New Detection Methods
A survey indicates a decline in cancer screening rates, contrasted by growing interest in at-home and multi-cancer early detection tests.
Read More
LIMA1-Alpha Protein Predicts Head and Neck Cancer Patients who Can Be Cured with Surgery Alone
Researchers have developed an LIMA1-alpha assay that can identify head and neck cancer patients who can be cured with surgery alone.
Read More
Pancreatic Cancer Has Genetic Early Warning System
Researchers have discovered how cellular stress and inflammation drive pancreatic cancer progression via the STAT3-ITGB3 pathway.
Read More
Blood Cancers Could Be Detected with Breath Test
Researchers have shown that molecules in exhaled breath can help detect blood cancer, paving the way for a lnon-invasive breathalyzer test.
Read More
Innovation Key to Reversing Decline in Routine Cancer Screenings
A new survey reveals declining cancer screening rates among U.S. adults, but shows strong interest in innovative screening methods.
Read More
- 1
- ...
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- 163
- 164
- 165
- 166
- 167
- 168
- 169
- 170
- 171
- 172
- 173
- 174
- 175
- 176
- 177
- 178
- 179
- 180
- 181
- 182
- 183
- 184
- ...
- 185